Results 121 to 130 of about 131,343 (196)

Association of the Rs738409 Polymorphism in <i>PNPLA3</i> with Development and Severity of Nonalcoholic Fatty Liver Disease. [PDF]

Indian J Endocrinol Metab
Das M, Biswas A, Goswami S, Deb R, Das S, Ray D.   +5 more
europepmc   +1 more source

Cross-sectional association between gallstone disease and nonalcoholic fatty liver disease: Exploring the mediating roles of hematological and biochemical markers. [PDF]

Medicine (Baltimore)
Li R, Wang B, Chen X, Cai A, Cao D, Zhou J.   +5 more
europepmc   +1 more source

Irisin and adropin decrease in preobese or obese individuals with nonalcoholic fatty liver disease. [PDF]

Turk J Med Sci
Mertoğlu C, Örek YŞ, Albayrak B, Arslan YK, Çoban A.   +4 more
europepmc   +1 more source

Differentially expressed genes and therapeutic targets for nonalcoholic fatty liver disease from transcriptomic techniques. [PDF]

Medicine (Baltimore)
Li J, Li Y, Zhang Y, Zhang S.
europepmc   +1 more source

miRNAs, lncRNAs, circRNAs and piRNAs in Nonalcoholic Fatty Liver Disease: Past, Present and Future. [PDF]

Int J Mol Sci
Lucaciu RL, Orasan OH, Hangan AC, Iancu M, Cozma A, Coste SC, Gog-Bogdan S, Sevastre B, Procopciuc LM.   +8 more
europepmc   +1 more source

ChREBP refines the hepatic response to fructose to protect the liver from injury [PDF]

, 2017
Angela M. Hall, Brian N. Finck, Hetz, Montgomery   +3 more
core   +3 more sources

Causal validation of immune antibody responses and nonalcoholic fatty liver disease: Evidence from Mendelian randomization and meta-analysis. [PDF]

Medicine (Baltimore)
Zhao Z, Guo Y, Hong S, Miao L.
europepmc   +1 more source

Prevalence of Nonalcoholic Fatty Liver Disease in Obese Patients and its Association with Insulin Resistance Markers.

J Pharm Bioallied Sci
Nayak J, Luke NE, Deshpande AV, Gupta S, Saiyad H, Farooqui S.   +5 more
europepmc   +1 more source

Association between serum insulin levels and ultrasound-defined nonalcoholic fatty liver disease: A cross-sectional study based on NHANES 2017-2020. [PDF]

Medicine (Baltimore)
Li M, Qiu S, Xiang M.
europepmc   +1 more source

Application of probiotic therapy in nonalcoholic fatty liver disease: mediating mechanism and future perspective. [PDF]

Front Cell Infect Microbiol
Luo XY, Huang WB, Lu CH, Gu W, Feng ZX, Shen S, Chen MZ, Zheng SS, Yang Z.   +8 more
europepmc   +1 more source